Registry Stop Signal

Biopsy before and after three weeks of study treatment

Biopsy before and after three weeks of study treatment is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Carcinoma, Ductal, Breast

Mechanism: Unknown

Modality: Unknown

Sponsor: West German Study Group

Scores

Risk-signal summary

Registry: 5/5

Timeline: 1/5

Recruitment burden: 0/5

Results availability: 0/5

Program risk: 3/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT01891357

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT01891357Registry Stop Signal (TERMINATED)stale_update_signalLow SignalNone